Cite
MLA Citation
Nathan Robison et al.. “LTBK-04. LATE BREAKING ABSTRACT: MEK162 (binimetinib) in children with progressive or recurrent low-grade glioma: a multi-institutional phase II and target validation study.” Neuro-oncology, vol. 24, n.d., pp. i191–i192. http://access.bl.uk/ark:/81055/vdc_100156699795.0x00001d